2021-01-06,Is Avenue Therapeutics (ATXI) Stock a Buy For 2021?
2020-12-18,Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis
2020-12-18,Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network
2020-12-17,Why Fortress Biotech Stock Jumped Today
2020-12-17,Avenue Therapeutics Provides Regulatory Update for IV Tramadol
2020-11-13,"Read This Before Selling Avenue Therapeutics, Inc. (NASDAQ:ATXI) Shares"
2020-10-28,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avenue Therapeutics, Inc. - ATXI"
2020-10-23,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avenue Therapeutics, Inc. - ATXI"
2020-10-14,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avenue Therapeutics, Inc. - ATXI"
2020-10-14,"Biotech Stock Roundup: REGN, GILD's Coronavirus News & Other Pipeline Updates"
2020-10-13,Avenue Therapeutics' Pain Drug Gets Complete Response Letter
2020-10-12,Avenue Therapeutics Sinks As FDA Rejects Opioid Pain Drug On Safety Concerns
2020-10-12,Why Fortress Biotech Stock Is Plunging Today
2020-10-12,Why Fortress Biotech's Stock Is Trading Lower Today
2020-10-12,Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
2020-09-09,Avenue Therapeutics Announces Publication of a Review of IV Tramadol
2020-08-17,Avenue Therapeutics (ATXI) Misses Earnings Estimates in Q2
2020-08-14,Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
2020-08-04,What's in Store for Avenue Therapeutics (ATXI) in Q2 Earnings?
2020-07-28,"Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know"
2020-07-22,"Avenue Therapeutics, Inc. (ATXI) Stock Sinks As Market Gains: What You Should Know"
2020-07-21,Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results
2020-07-16,"Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know"
2020-07-09,"Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know"
2020-07-09,Is Avenue Therapeutics (ATXI) Stock Outpacing Its Medical Peers This Year?
2020-07-07,Pacira (PCRX) Provides Preliminary Results for Second Quarter
2020-06-29,Fortress Biotech Added to Russell 3000Â® Index
2020-06-25,Veru (VERU) Soars: Stock Adds 6.9% in Session
2020-06-24,"Avenue Therapeutics, Inc. (ATXI) Upgraded to Strong Buy: Here's What You Should Know"
2020-06-24,New Strong Buy Stocks for June 24th
2020-06-23,"Avenue Therapeutics' Shares March Higher, Can It Continue?"
2020-06-18,Aclaris Gets FDA Nod to Start Investigator-led Coronavirus Study
2020-06-18,NGM Biopharmaceuticals (NGM) Soars: Stock Adds 7.8% in Session
2020-06-17,Is Avenue Therapeutics (ATXI) Outperforming Other Medical Stocks This Year?
2020-06-16,Provention Bio (PRVB) Looks Good: Stock Adds 8.6% in Session
2020-06-15,"Zacks.com featured highlights include: Frontline, iClick Interactive Asia, Avenue Therapeutics, ProQR Therapeutics and BJ???s Wholesale Club"
2020-06-11,NantHealth (NH) Looks Good: Stock Adds 9.1% in Session
2020-06-11,Otonomy (OTIC) in Focus: Stock Moves 6.1% Higher
2020-06-10,Recro Pharma (REPH) in Focus: Stock Moves 7.6% Higher
2020-06-09,"Zacks.com featured highlights include: Avenue Therapeutics, Calix, ChannelAdvisor and Magic Software Enterprises"
2020-06-08,4 Affordable Breakout Stocks for Stunning Returns
2020-06-05,Avenue Therapeutics Announces Publications in Peer-Reviewed Journals
2020-05-29,"Avenue Therapeutics' Shares March Higher, Can It Continue?"
2020-05-29,"Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne"
2020-05-29,Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders
2020-05-28,Flexion (FLXN) Soars: Stock Adds 6.6% in Session
2020-05-27,"Hedge Funds Watching Avenue Therapeutics, Inc. (ATXI) From Afar"
2020-05-27,Is Avenue Therapeutics (ATXI) Stock Outpacing Its Medical Peers This Year?
2020-05-27,Small Drug Industry Prospects Bright Amid Coronavirus Gloom
2020-05-26,"Zacks.com featured highlights include: Veritone, Avenue Therapeutics, Turtle Beach, BJ???s Wholesale Club and Atlas Air Worldwide"
2020-05-26,"Zacks.com featured highlights include: Avenue Therapeutics, Glu Mobile, Yamana Gold and Z Holdings"
2020-05-26,How Avenue (ATXI) Stock Stands Out in a Strong Industry
2020-05-22,Pick These 5 Stocks With Superb Relative Price Strength
2020-05-22,4 Breakout Stocks for Impressive Returns
2020-05-11,Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
2020-04-27,Top Ranked Momentum Stocks to Buy for April 27th
2020-04-24,"The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia"
2020-04-23,Why Avenue Therapeutics (ATXI) Stock Might be a Great Pick
2020-04-23,Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
2020-04-23,5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
2020-04-16,"Avenue Therapeutics, Inc. (ATXI) Upgraded to Strong Buy: Here's Why"
2020-03-30,Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
2020-02-13,Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
2019-12-13,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer"
2019-12-11,Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
2019-11-04,Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
2019-10-28,Avenue Therapeutics Announces Publication of IV Tramadol Phase 1 Clinical Data in Clinical Pharmacology in Drug Development
2019-10-18,Avenue Therapeutics to Present Phase 3 Bunionectomy Study of IV Tramadol at the American Society of Anesthesiologists Annual Meeting
2019-08-14,Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
2019-08-01,Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors
2019-06-07,3 Foolproof Strategies To Minimize Risk
2019-06-03,Avenue Therapeutics Trades Higher After Phase 3 Success
2019-06-03,Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
2019-05-13,Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
2019-04-30,Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors
2019-03-12,Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
2019-02-11,Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary)
2019-01-28,ATXI: How Much Are CVRs Worth?
2019-01-19,"Stull, Stull & Brody Announces Class Action Suit on Behalf of Purchasers of the Securities of Avenue Therapeutics, Inc. (NasdaqCM: ATXI)"
2018-12-19,Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain
2018-12-12,"SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Avenue Therapeutics, Inc. - ATXI"
2018-12-03,ATXI: InvaGen Acquisition Spices Up Quarterly Report
2018-11-21,"Research Report Identifies Chicken Soup for the Soul Entertainment, Allied Motion Technologies, Bandwidth, Solid Biosciences, Avenue Therapeutics, and BeyondSpring with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement"
2018-11-14,Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
2018-11-13,ATXI: InvaGen Capital Raise & Acquisition
2018-11-13,InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.
2018-08-27,ATXI: Second Quarter 2018 Results
2018-08-14,Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
2018-08-02,Special Report: Biotech incubator taps investors through in-house brokerage
2018-08-02,Special Report: Biotech incubator taps investors through in-house brokerage
2018-06-19,Avenue Therapeutics to Participate in JMP Securities Life Sciences Conference
2018-06-12,ATXI: KOL Call with Drs. Singla and Minkowitz on IV Tramadol
2018-06-06,Avenue Therapeutics to Host Key Opinion Leader Call on Intravenous (IV) Tramadol for the Management of Postoperative Pain
2018-05-23,Blog Exposure - Avenue Therapeutics Reported Positive Results from Pivotal Phase-3 Trial of IV Tramadol
2018-05-21,Benzinga Pro's 5 Stocks To Watch Today
2018-05-21,Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
2018-05-14,ATXI: 1Q:18 Update Confirms Timeline
2018-05-03,Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
2018-04-10,ATXI: No Pain? We See a Gain; Developing Tramadol
2018-03-28,Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol
